News
Oruka Therapeutics
ORKA · NASDAQ
$79.09+$4.61 (+6.19%)TodayMarket closed ·
Prev close $74.48
Latest news
- NewsVandana Singh
Oruka Therapeutics Says Psoriasis Drug Shows Deepening Efficacy
- Press releaseGlobe Newswire
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- NewsTanya Rawat
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares
- Press releaseGlobe Newswire
Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation
- Press releaseGlobe Newswire
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
- Press releaseGlobe Newswire
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
- Press releasePRNewswire
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
- NewsVandana Singh
Oruka Therapeutics Stock Explodes As Psoriasis Data Shows 'Highly Compelling' Skin Clearance
- Press releaseGlobe Newswire
Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis
- Press releaseGlobe Newswire
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseGlobe Newswire
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
- Press releaseGlobe Newswire
Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
- NewsGianni di Poce
The Insider Report: The Bulls Can Thank Tech
- Press releaseGlobe Newswire
Oruka Therapeutics to Present at Multiple November Investor Conferences
- NewsRishabh Mishra
Stock Market Today: Dow Jones, Nasdaq, Futures Gain As Government Enters 2nd Week Of Shutdown—Plug, Lithium Americas, UiPath In Focus (UPDATED)
- NewsAvi Kapoor
Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday
- NewsAvi Kapoor
Why New Fortress Energy Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001
- Press releaseGlobe Newswire
Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer
- Press releaseGlobe Newswire
Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference
- NewsAvi Kapoor
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Oruka Therapeutics to Present at Multiple March Investor Conferences
- NewsAvi Kapoor
PayPal, Estée Lauder, UBS And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Oruka Therapeutics to Present at Multiple November Investor Conferences
- NewsAvi Kapoor
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.